ALK and anaplastic large cell lymphoma: Conversely, ALK-negative ALCL possesses recurrent gain-of-function mutations in JAK1 and/or STAT3, as well as rare SVs involving tyrosine kinase genes, such as ROS1 and TYK2(38).